Advertisement
Home »

Rivaroxaban treatment for asymptomatic venous thromboembolism: insights from the J’xactly study.

Aug 21, 2023

ABOUT THE EXPERTS

  • Shohei Migita

    Division of Cardiology, Department of Medicine, Nihon University School of Medicine, Ohyaguchi-kamicho, Itabashi-ku, Tokyo, 173-8610, Japan.

    Yasuo Okumura

    Division of Cardiology, Department of Medicine, Nihon University School of Medicine, Ohyaguchi-kamicho, Itabashi-ku, Tokyo, 173-8610, Japan. okumura.yasuo@nihon-u.ac.jp.

    Ikuo Fukuda

    Department of Cardiology, Keimeikai Yokawa Hospital, Miki, Japan.

    Mashio Nakamura

    Nakamura Medical Clinic, Kuwana, Japan.

    Norikazu Yamada

    Department of Cardiology, Kuwana City Medical Center, Kuwana, Japan.

    Morimasa Takayama

    Department of Cardiology, Sakakibara Heart Institute, Fuchu, Japan.

    Hideaki Maeda

    Department of Heart and Vascular Center, Ukima Central Hospital, Tokyo, Japan.

    Takeshi Yamashita

    Department of Cardiovascular Medicine, The Cardiovascular Institute, Tokyo, Japan.

    Takanori Ikeda

    Department of Cardiovascular Medicine, Toho University Faculty of Medicine, Tokyo, Japan.

    Makoto Mo

    Department of Cardiovascular Surgery, Yokohama Minami Kyosai Hospital, Yokohama, Japan.

    Tsutomu Yamazaki

    Innovation and Research Support Center, International University of Health and Welfare, Tokyo, Japan.

    Atsushi Hirayama

    Department of Cardiology, Osaka Police Hospital, Osaka, Japan.

REFERENCES & ADDITIONAL READING

PubMed

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

Advertisement